FilingReader Intelligence

Fosun Pharma launches dual share incentive plans

August 22, 2025 at 06:33 PM UTCBy FilingReader AI

Shanghai Fosun Pharmaceutical announced two parallel incentive schemes for 2025: an A-share stock option plan and an H-share restricted share unit plan.

The A-share plan proposes granting up to 5,726,100 stock options, with a first grant of 4,580,900 options at an exercise price of 27.93 yuan per share.

The H-share plan offers up to 13,370,500 restricted share units, with an initial grant of 10,696,400 units, purchasable at 1.00 yuan per unit after vesting.

Both initiatives will be funded by repurchased shares.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:600196Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip

News Alerts

Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →